Recurrent KRAS codon 146 mutations in human colorectal cancer
- 1 August 2006
- journal article
- research article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 5 (8) , 928-932
- https://doi.org/10.4161/cbt.5.8.3251
Abstract
International academic publisher with offices worldwide. Publishing more than 2,100 journals, over 4,000 new books each year, with a books backlist in excess of 60,000 specialist titles. We are one of the world’s leading publishers of scholarly journals, books, eBooks, textbooks and reference worksKeywords
This publication has 21 references indexed in Scilit:
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotypeAnnals of Oncology, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- A novel point mutation at codon 146 of the K-ras gene in a human colorectal cancer identified by the polymerase chain reactionVirus Genes, 1991
- Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation.Molecular and Cellular Biology, 1990
- The HuT series of ‘carcinogen-transformed’ human fibroblast cell lines are derived from the human fibrosarcoma cell line 8387Carcinogenesis: Integrative Cancer Research, 1988
- Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins.Molecular and Cellular Biology, 1988
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982
- Mechanism of activation of a human oncogeneNature, 1982
- Neoplastic transformation of human diploid fibroblast cells by chemical carcinogensProceedings of the National Academy of Sciences, 1978